Mirador Capital Partners LP Abbott Laboratories Transaction History

Mirador Capital Partners LP

$520 Million
Q1 2024

A detailed history of Mirador Capital Partners LP transactions in Abbott Laboratories stock. As of the latest transaction made, Mirador Capital Partners LP holds 3,026 shares of ABT stock, worth $314,764. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,026

Previous 3,025 0.03%

Holding current value

$314,764

Previous $332,000 3.31%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $109 - $120	1 Added 0.03%	3,026 $343,000
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $26,515 - $32,457	-294 Reduced 8.86%	3,025 $332,000
Q3 2023 Oct 05, 2023	SELL	$95.53 - $114.62 $28,754 - $34,500	-301 Reduced 8.31%	3,319 $321,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $33,962 - $37,841	337 Added 10.27%	3,620 $394,000
Q1 2023 Apr 14, 2023	SELL	$96.86 - $114.01 $4,164 - $4,902	-43 Reduced 1.29%	3,283 $332,000

Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $285 - $334	3 Added 0.09%	3,326 $365,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $193 - $224	2 Added 0.06%	3,323 $322,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $6,532 - $7,895	-64 Reduced 1.89%	3,321 $361,000
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $342 - $417	3 Added 0.09%	3,385 $401,000
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $7,278 - $8,911	63 Added 1.9%	3,382 $476,000
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $349 - $387	3 Added 0.09%	3,319 $392,000
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $22,004 - $25,902	-208 Reduced 5.9%	3,316 $384,000
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 5.37%	3,524 $422,000
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $315 - $343	3 Added 0.08%	3,724 $408,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $10,355 - $12,575	-113 Reduced 2.95%	3,721 $405,000
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $26,033 - $33,320	340 Added 9.73%	3,834 $351,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $52,768 - $77,162	840 Added 31.65%	3,494 $318,000
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $17,821 - $19,839	-227 Reduced 7.88%	2,654 $231,000
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $2,946 - $3,194	36 Added 1.27%	2,881 $241,000
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $1,238 - $1,445	-17 Reduced 0.59%	2,845 $239,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $1,258 - $1,521	19 Added 0.67%	2,862 $229,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $228,279 - $258,608	-3,482 Reduced 55.05%	2,843 $206,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $15,810 - $19,073	260 Added 4.29%	6,325 $464,000
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $58,375 - $64,429	-1,014 Reduced 14.32%	6,065 $370,000
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $8,440 - $9,543	150 Added 2.16%	7,079 $412,000
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $11,058 - $11,838	206 Added 3.06%	6,929 $395,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $3,364 - $3,754	70 Added 1.05%	6,723 $361,000
Q2 2017 Aug 08, 2017	BUY	N/A	6,653	6,653 $328,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account

Mirador Capital Partners LP Abbott Laboratories Transaction History